MarketsandMarkets: Year 2008 Recorded Highest Number of Clinical Trials (10,326) during the Study Period (2007-2010)By Marketsandmarkets, PRNE
Wednesday, September 7, 2011
DALLAS, September 8, 2011 -
The report “Global Clinical Trials Market (2007 - 2010)” analyses the total number of clinical trials conducted globally from 2007 to 2010 by phases, study design, indications, and major market drivers, restraints, and opportunities for the clinical trials market in North America, South America, Europe, and Asia.
Browse market data tables and in-depth TOC on Global Clinical Trials Market (2007 - 2010)
Early buyers will receive 10% customization of reports.
Clinical trials market now witness a paradigm shift. Naïve heterogeneous patient populations in the developing nations are opening up new avenues for the clinical trials market. Developing countries also offer faster go to market which is triggering major pharmaceutical companies to direct their investment in these regions. Apart from this, stringent regulations and tight R&D budgets in the Pharma-Biotech industry are also forcing companies to move to east. This scenario has further boosted the alliances between the pharma-biotech companies and the clinical research organizations, with the latter accounting for major chunk of the trials conducted.
Today, emerging countries account for the largest share of the phase II/III (prime stages) clinical trials conducted globally with major focus on oncology, Alzheimer’s, metabolic and cardiovascular diseases. Support from the respective government bodies is one of the major factors affecting the clinical trials market. Clinical trials sponsored by the industry have a much higher share in the market as compared to government organizations.
The key players (Clinical Research Organizations) in the market include Chiltern, Omnicare, PPD, Parexel, Kendle and Quintles.
The global clinical trials conducted in the year 2008 were reported to be 10,326 and were highest from 2007 to 2010. Oncology trials were the most widely conducted clinical trials accounting for 28.47% of all the trials conducted for the year 2008. Asia reported to a steady growth as compared to other regions which showed decline in the total number of clinical trials in the year 2010.
Other Reports by MarketsandMarkets
- Fetal Equipment Market
- Diagnostic Imaging Market
- U.S. Electronic Medical Records Market
- Worldwide Electronic Medical Records Market
- DNA Market
- Healthcare IT Market
- Diabetes Care Devices Market
- Biopharmaceutical Market
- PET/SPECT Market
- Stem Cell Technologies Market
- Biomarkers Market
Upcoming Market Research by MarketsandMarkets
- Prostate Cancer Drugs Market
- Chronic Lymphocytic Leukemia Market
- Multiple Myeloma Drugs Market
- Breast Cancer Drugs Market www.marketsandmarkets.com/Market-Reports/healthcare-cloud-347.html
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.
MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website www.marketsandmarkets.com
7557 Rambler Road,
Suite 727, Dallas, TX 75231
Tags: Dallas, MarketsandMarkets, September 8, texas